TAGIPHARMA
Live / Registered — Registered and renewed (as of 26 Apr 2022)
What this means for you
Registered since 13 Nov 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Nov 2022).
Record
- Serial number
- 85264884
- Registration number
- 4242706
- Mark type
- Design + words
- Filed
- 11 Mar 2011
- Published for opposition
- 12 Jun 2012
- Registered
- 13 Nov 2012
- Next maintenance due
- 13 Nov 2022
- Attorney of record
- William A. Reilly II
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of eating disorders, psychotic disorders, respiratory disorders, skin care, and aches and pains; Pharmaceuticals for use in the treatment of digestive and gastrointestinal disorders
Owner
- TAGI Pharma, Inc, South Beloit, IL, US
- TAGI Pharma, Inc, South Beloit, IL, US
- TAGI Pharma, Inc, South Beloit, IL, US
Prosecution history
- 26 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 26 Apr 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 26 Apr 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 26 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Dec 2021 — TEAS SECTION 8 & 9 RECEIVED
- 13 Nov 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Jan 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Jan 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Dec 2017 — TEAS SECTION 8 & 15 RECEIVED
- 13 Nov 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Nov 2012 — REGISTERED-PRINCIPAL REGISTER
- 06 Oct 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Oct 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 05 Oct 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED